KKR is said to be deepening its India healthcare bet with a $1.39 billion acquisition of Medicover's India hospital business
KKR is acquiring the India hospital business of Medicover, the Nasdaq Stockholm-listed European healthcare group, in a deal valued at approximately $1.39 billion (EUR 1.2 billion), in what would represent a significant expansion of the private equity firm's healthcare portfolio in India. The transaction signals continued appetite among large global buyout funds for healthcare assets in fast-growing emerging markets, where demographic trends and rising middle-class demand for private medical services are driving deal activity. India has become one of the most active destinations for private equity healthcare investment in 2026, with deal volumes accelerating as sponsors compete for quality assets in a sector that has historically delivered strong returns. The Medicover transaction, if completed, would rank among the larger healthcare private equity deals in the Indian market this year. No legal advisers have been named in connection with the transaction.
Why this matters
The scale of the reported deal reflects the sustained conviction among global private equity sponsors that Indian healthcare remains one of the most attractive deployment opportunities available, combining volume-driven demand growth with relatively limited domestic competition for quality platform assets. A deal of this size in an emerging market context typically requires navigation of foreign direct investment (FDI) approval processes, sector-specific regulatory clearances, and multi-jurisdiction structuring. The transaction also illustrates the broader trend of large-cap sponsors moving beyond traditional Western markets to deploy capital at scale, a pattern that has intensified as European and US deal multiples have risen.
On the Ground
A transaction of this type activates private equity M&A, leveraged finance, regulatory clearance, and cross-border structuring practices. Counsel on each side would be advising on deal documentation including share purchase agreements and conditions precedent, FDI regulatory approvals, and due diligence on regulated healthcare businesses. A trainee on this matter would assist with due diligence report indexing, drafting conditions precedent checklists, and coordinating Companies House equivalent filings in the relevant jurisdiction.
Interview prep
Question you might get
“What regulatory and structural challenges would KKR face in completing a $1.39 billion healthcare acquisition in India, and how would you advise on managing them?”
Sign up free to see the full answer
A model answer you can lift into an interview — how to frame this story for a partner.
Sign up freeMy notes
saved